1. Home
  2. GRI vs GCDT Comparison

GRI vs GCDT Comparison

Compare GRI & GCDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GRI Bio Inc.

GRI

GRI Bio Inc.

HOLD

Current Price

$1.99

Market Cap

4.5M

Sector

Health Care

ML Signal

HOLD

GCDT

Green Circle Decarbonize Technology Limited Ordinary Shares

N/A

Current Price

$1.05

Market Cap

5.3M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
GRI
GCDT
Founded
2018
1992
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
4.5M
5.3M
IPO Year
2020
2022

Fundamental Metrics

Financial Performance
Metric
GRI
GCDT
Price
$1.99
$1.05
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$160.00
N/A
AVG Volume (30 Days)
817.2K
252.9K
Earning Date
05-15-2026
05-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.18
$0.33
52 Week High
$6.70
$5.32

Technical Indicators

Market Signals
Indicator
GRI
GCDT
Relative Strength Index (RSI) 51.80 78.73
Support Level $0.20 $0.55
Resistance Level $2.53 $1.19
Average True Range (ATR) 0.28 0.08
MACD 0.06 0.03
Stochastic Oscillator 21.06 100.00

Price Performance

Historical Comparison
GRI
GCDT

About GRI GRI Bio Inc.

GRI Bio Inc is a clinical-stage biotech company focused on discovering, developing, and commercializing therapies targeting serious diseases associated with dysregulated immune responses that to inflammatory, fibrotic, and autoimmune disorders. GRI Bio's program, GRI-0621, is a small molecule RAR-beta and gamma dual agonist that inhibits the activity of human NKT I cells, returning the immune system to homeostasis. It is also an oral formulation of tazarotene, a synthetic RAR-beta and gamma selective agonist for the topical treatment of psoriasis and acne. The company's other product candidate GRI-0803 is a novel oral agonist of type 2 Natural Killer T (type 2 NKT) cells which can be a potential treatment for autoimmune disorders.

About GCDT Green Circle Decarbonize Technology Limited Ordinary Shares

Green Circle Decarbonize Technology Ltd is a company which provides advanced energy saving solutions supported by proprietary phase change thermal energy storage materials and thermal engineering services. As an advocate of decarbonization, the Company designs, develops and provides customized energy saving solutions that bring considerable economic benefits to our clients and reduce carbon emissions for a sustainable future.

Share on Social Networks: